Filing Details
- Accession Number:
- 0001290929-23-000008
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-02-13 21:41:29
- Reporting Period:
- 2023-02-10
- Accepted Time:
- 2023-02-13 21:41:29
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
316253 | Enzo Biochem Inc | ENZ | Services-Medical Laboratories (8071) | 132866202 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1419248 | G. James Wolf | 105, Flyway Drive Kiawah Island SC 29455 | No | No | No | Yes |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock, $0.01 Par Value | Acquisiton | 2023-02-10 | 5,000 | $1.29 | 4,095,000 | No | 4 | P | Direct | |
Common Stock, $0.01 Par Value | Acquisiton | 2023-02-13 | 5,000 | $1.29 | 4,100,000 | No | 4 | P | Direct | |
Common Stock, $0.01 Par Value | Acquisiton | 2023-02-13 | 5,000 | $1.29 | 115,000 | No | 4 | P | Indirect | See Footnote |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct | |
No | 4 | P | Direct | |
No | 4 | P | Indirect | See Footnote |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock, $0.01 Par Value | Long Call Option (right to buy) | Disposition | 2023-02-13 | 324 | $0.19 | 32,400 | $5.00 |
Common Stock, $0.01 Par Value | Short Put Option (obligation to buy) | Acquisiton | 2023-02-13 | 324 | $1.01 | 32,400 | $2.50 |
Common Stock, $0.01 Par Value | Short Put Option (obligation to buy) | Disposition | 2023-02-13 | 750 | $0.03 | 75,000 | $7.50 |
Common Stock, $0.01 Par Value | Short Put Option (obligation to buy) | Acquisiton | 2023-02-13 | 750 | $1.12 | 75,000 | $2.50 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
483 | 2022-10-28 | 2023-04-21 | No | 4 | S | Direct |
324 | 2023-02-13 | 2023-07-21 | No | 4 | S | Direct |
0 | 2022-10-28 | 2023-04-21 | No | 4 | S | Direct |
2,163 | 2023-02-13 | 2023-04-21 | No | 4 | S | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock, $0.01 Par Value | 308,500 | Indirect | See Footnote |
Reported Derivative Holdings
Sec. Name | Sec. Type | Price | Date | Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
---|---|---|---|---|---|---|---|
Common Stock, $0.01 Par Value | Long Call Option (right to buy) | $2.50 | 2022-10-28 | 2023-04-21 | 100,000 | 1,000 | Direct |
Expiration Date | Amount | Remaning Holdings | Nature of Ownership |
---|---|---|---|
2023-04-21 | 100,000 | 1,000 | Direct |
Footnotes
- The transaction was completed in the name and for the benefit of the Reporting Person's sibling. The Reporting Person maintains a power of attorney granted by the Reporting Person's sibling with respect to these shares, including voting and dispositive power over the shares. The Reporting Person has no pecuniary interest in the shares and disclaims beneficial ownership of the securities held by his sibling. This report will not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.
- The 308,500 shares owned indirectly by the Reporting Person include 116,000 shares held in qualified retirement accounts in the name, and for the benefit, of the Reporting Person, 22,000 shares held in qualified retirement accounts in the name, and for the benefit, of the Reporting Person's spouse and 170,500 shares owned directly by adult children of the Reporting Person.